2021 Annual Meeting | S18 - Health Care Disparities
Program Materials Program Evaluations
| 04:00 PM - 04:08 PM EDT | Abstract |
001 - Sociodemographic and Clinical Characteristics of Patients With Multiple Sclerosis by Race and Ethnicity (NARCRMS Registry)
Victor M. Rivera, MD, FAAN |
| 04:08 PM - 04:16 PM EDT | Abstract |
002 - Race/ethnicity and Insurance Status Impact Acute Ischemic Stroke Treatment within Three Large U.S. States
Alison Herman |
| 04:16 PM - 04:24 PM EDT | Q&A |
Questions and Answers
|
| 04:24 PM - 04:32 PM EDT | Abstract |
003 - Racial Disparities with Last Known Normal Time in patients with Acute Ischemic Stroke
Mangala Gopal, MD |
| 04:32 PM - 04:40 PM EDT | Abstract |
004 - An Assessment of Gender and Racial/Ethnic Diversity amongst Neurology Residents and Physicians
|
| 04:40 PM - 04:48 PM EDT | Abstract |
005 - Creation of a Longitudinal, Clinical Undergraduate Pipeline Program to Engage Underrepresented Individuals in Neurology
Robert I. Thompson-Stone, MD, FAAN |
| 04:48 PM - 05:00 PM EDT | Q&A |
Questions and Answers
|
| Guido J. Falcone, MD | The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA. |
| Wanda Castro-Borrero, MD | Dr. Castro-Borrero has received personal compensation for serving as an employee of BIOGEN. Dr. Castro-Borrero has received stock or an ownership interest from BIOGEN. |
| Jennifer A. Kim, MD | Dr. Kim has nothing to disclose. |
| Pavle Repovic, MD, PhD | Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela/Horizon. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI. Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Celgene/BristolMyersSquibb. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viela. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Repovic has received research support from Genentech. The institution of Dr. Repovic has received research support from Biogen. |
| No disclosure on file | |
| Victor M. Rivera, MD, FAAN | Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rivera has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Laboratories. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LACTRIMS. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Central American Forum on MS. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bracken Law Firm, El Paso, TX. |
| Toni Saldana-King | Toni Saldana-King has received personal compensation for serving as an employee of Biogen. Toni Saldana-King has received stock or an ownership interest from Biogen. |
| Lindsey R. Kuohn, MD | Dr. Kuohn has nothing to disclose. |
| Mangala Gopal, MD | Dr. Gopal has nothing to disclose. |
| Robert I. Thompson-Stone, MD, FAAN | Dr. Thompson-Stone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Conway Homer PC. |
| David Y. Hwang, MD, FAAN | The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received publishing royalties from a publication relating to health care. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services. |
| Kevin N. Sheth, MD, FAAN | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| Coraly Perez Bajandas | Ms. Perez Bajandas has received personal compensation for serving as an employee of Biogen. Ms. Perez Bajandas has received stock or an ownership interest from Biogen. |
| Alison Herman | Ms. Herman has nothing to disclose. |
| Vivien H. Lee, MD, FAAN | Dr. Lee has nothing to disclose. |
| Richa Sharma, MD | Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care. |
| Payal B. Patel, MD | The institution of Dr. Patel has received research support from National Institute of Health. The institution of Dr. Patel has received research support from AHRQ. Dr. Patel has received personal compensation in the range of $0-$499 for serving as a Author with MedLink Neurology. |
| Daniel Jose Correa, MD, MSc, FAAN | Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Correa has stock in Aidin Inc. Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc. |